ICD-10-CM FY2025 code changes

C00-D49 — Neoplasms (63)

• C81.0A — Nodular lymphocyte predominant Hodgkin lymphoma, in remission
• C81.1A — Nodular sclerosis Hodgkin lymphoma, in remission
• C81.2A — Mixed cellularity Hodgkin lymphoma, in remission
• C81.3A — Lymphocyte depleted Hodgkin lymphoma, in remission
• C81.4A — Lymphocyte-rich Hodgkin lymphoma, in remission
• C81.7A — Other Hodgkin lymphoma, in remission
• C81.9A — Hodgkin lymphoma, unspecified, in remission
• C82.0A — Follicular lymphoma grade I, in remission
• C82.1A — Follicular lymphoma grade II, in remission
• C82.2A — Follicular lymphoma grade III, unspecified, in remission
• C82.3A — Follicular lymphoma grade IIIa, in remission
• C82.4A — Follicular lymphoma grade IIIb, in remission
• C82.5A — Diffuse follicle center lymphoma, in remission
• C82.6A — Cutaneous follicle center lymphoma, in remission
• C82.8A — Other types of follicular lymphoma, in remission
• C82.9A — Follicular lymphoma, unspecified, in remission
• C83.0A — Small cell B-cell lymphoma, in remission
• C83.1A — Mantle cell lymphoma, in remission
• C83.390 — Primary central nervous system lymphoma
• C83.398 — Diffuse large B-cell lymphoma of other extranodal and solid organ sites
• C83.3A — Diffuse large B-cell lymphoma, in remission
• C83.5A — Lymphoblastic (diffuse) lymphoma, in remission
• C83.7A — Burkitt lymphoma, in remission
• C83.8A — Other non-follicular lymphoma, in remission
• C83.9A — Non-follicular (diffuse) lymphoma, unspecified, in remission
• C84.0A — Mycosis fungoides, in remission
• C84.1A — Sezary disease, in remission
• C84.4A — Peripheral T-cell lymphoma, not elsewhere classified, in remission
• C84.6A — Anaplastic large cell lymphoma, ALK-positive, in remission
• C84.7B — Anaplastic large cell lymphoma, ALK-negative, in remission
• C84.9A — Mature T/NK-cell lymphomas, unspecified, in remission
• C84.AA — Cutaneous T-cell lymphoma, unspecified, in remission
• C84.ZA — Other mature T/NK-cell lymphomas, in remission
• C85.1A — Unspecified B-cell lymphoma, in remission
• C85.2A — Mediastinal (thymic) large B-cell lymphoma, in remission
• C85.8A — Other specified types of non-Hodgkin lymphoma, in remission
• C85.9A — Non-Hodgkin lymphoma, unspecified, in remission
• C86.00 — Extranodal NK/T-cell lymphoma, nasal type not having achieved remission
• C86.01 — Extranodal NK/T-cell lymphoma, nasal type, in remission
• C86.10 — Hepatosplenic T-cell lymphoma not having achieved remission
• C86.11 — Hepatosplenic T-cell lymphoma, in remission
• C86.20 — Enteropathy-type (intestinal) T-cell lymphoma not having achieved remission
• C86.21 — Enteropathy-type (intestinal) T-cell lymphoma, in remission
• C86.30 — Subcutaneous panniculitis-like T-cell lymphoma not having achieved remission
• C86.31 — Subcutaneous panniculitis-like T-cell lymphoma, in remission
• C86.40 — Blastic NK-cell lymphoma not having achieved remission
• C86.41 — Blastic NK-cell lymphoma, in remission
• C86.50 — Angioimmunoblastic T-cell lymphoma not having achieved remission
• C86.51 — Angioimmunoblastic T-cell lymphoma, in remission
• C86.60 — Primary cutaneous CD30-positive T-cell proliferations not having achieved remission
• C86.61 — Primary cutaneous CD30-positive T-cell proliferations, in remission
• C88.00 — Waldenstrom macroglobulinemia not having achieved remission
• C88.01 — Waldenstrom macroglobulinemia, in remission
• C88.20 — Heavy chain disease not having achieved remission
• C88.21 — Heavy chain disease, in remission
• C88.30 — Immunoproliferative small intestinal disease not having achieved remission
• C88.31 — Immunoproliferative small intestinal disease, in remission
• C88.40 — Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma] not having achieved remission
• C88.41 — Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma], in remission
• C88.80 — Other malignant immunoproliferative diseases not having achieved remission
• C88.81 — Other malignant immunoproliferative diseases, in remission
• C88.90 — Malignant immunoproliferative disease, unspecified not having achieved remission
• C88.91 — Malignant immunoproliferative disease, unspecified, in remission

D50-D89 — Diseases of the Blood and Blood-forming Organs and Certain Disorders Involving the Immune Mechanism (1)

• D61.03 — Fanconi anemia

E00-E89 — Endocrine, Nutritional and Metabolic Diseases (20)

• E10.A — Type 1 diabetes mellitus, presymptomatic
• E10.A0 — Type 1 diabetes mellitus, presymptomatic, unspecified
• E10.A1 — Type 1 diabetes mellitus, presymptomatic, Stage 1
• E10.A2 — Type 1 diabetes mellitus, presymptomatic, Stage 2
• E16.A — Hypoglycemia level
• E16.A1 — Hypoglycemia level 1
• E16.A2 — Hypoglycemia level 2
• E16.A3 — Hypoglycemia level 3
• E34.00 — Carcinoid syndrome, unspecified
• E34.01 — Carcinoid heart syndrome
• E34.09 — Other carcinoid syndrome
• E66.81 — Obesity class
• E66.811 — Obesity, class 1
• E66.812 — Obesity, class 2
• E66.813 — Obesity, class 3
• E66.89 — Other obesity not elsewhere classified
• E74.82 — Disorders of citrate metabolism
• E74.820 — SLC13A5 Citrate Transporter Disorder
• E74.829 — Other disorders of citrate metabolism
• E88.82 — Obesity due to disruption of MC4R pathway

F01-F99 — Mental, Behavioral and Neurodevelopmental Disorders (26)

• F50.010 — Anorexia nervosa, restricting type, mild
• F50.011 — Anorexia nervosa, restricting type, moderate
• F50.012 — Anorexia nervosa, restricting type, severe
• F50.013 — Anorexia nervosa, restricting type, extreme
• F50.014 — Anorexia nervosa, restricting type, in remission
• F50.019 — Anorexia nervosa, restricting type, unspecified
• F50.020 — Anorexia nervosa, binge eating/purging type, mild
• F50.021 — Anorexia nervosa, binge eating/purging type, moderate
• F50.022 — Anorexia nervosa, binge eating/purging type, severe
• F50.023 — Anorexia nervosa, binge eating/purging type, extreme
• F50.024 — Anorexia nervosa, binge eating/purging type, in remission
• F50.029 — Anorexia nervosa, binge eating/purging type, unspecified
• F50.20 — Bulimia nervosa, unspecified
• F50.21 — Bulimia nervosa, mild
• F50.22 — Bulimia nervosa, moderate
• F50.23 — Bulimia nervosa, severe
• F50.24 — Bulimia nervosa, extreme
• F50.25 — Bulimia nervosa, in remission
• F50.810 — Binge eating disorder, mild
• F50.811 — Binge eating disorder, moderate
• F50.812 — Binge eating disorder, severe
• F50.813 — Binge eating disorder, extreme
• F50.814 — Binge eating disorder, in remission
• F50.819 — Binge eating disorder, unspecified
• F50.83 — Pica in adults
• F50.84 — Rumination disorder in adults

G00-G99 — Diseases of the Nervous System (8)

• G40.84 — KCNQ2-related epilepsy
• G40.841 — KCNQ2-related epilepsy, not intractable, with status epilepticus
• G40.842 — KCNQ2-related epilepsy, not intractable, without status epilepticus
• G40.843 — KCNQ2-related epilepsy, intractable, with status epilepticus
• G40.844 — KCNQ2-related epilepsy, intractable, without status epilepticus
• G90.81 — Serotonin syndrome
• G90.89 — Other disorders of autonomic nervous system
• G93.45 — Developmental and epileptic encephalopathy

I00-I99 — Diseases of the Circulatory System (4)

• I26.03 — Cement embolism of pulmonary artery with acute cor pulmonale
• I26.04 — Fat embolism of pulmonary artery with acute cor pulmonale
• I26.95 — Cement embolism of pulmonary artery without acute cor pulmonale
• I26.96 — Fat embolism of pulmonary artery without acute cor pulmonale

J00-J99 — Diseases of the Respiratory System (10)

• J34.82 — Nasal valve collapse
• J34.820 — Internal nasal valve collapse
• J34.8200 — Internal nasal valve collapse, unspecified
• J34.8201 — Internal nasal valve collapse, static
• J34.8202 — Internal nasal valve collapse, dynamic
• J34.821 — External nasal valve collapse
• J34.8210 — External nasal valve collapse, unspecified
• J34.8211 — External nasal valve collapse, static
• J34.8212 — External nasal valve collapse, dynamic
• J34.829 — Nasal valve collapse, unspecified

K00-K95 — Diseases of the Digestive System (33)

• K60.30 — Anal fistula, unspecified
• K60.31 — Anal fistula, simple
• K60.311 — Anal fistula, simple, initial
• K60.312 — Anal fistula, simple, persistent
• K60.313 — Anal fistula, simple, recurrent
• K60.319 — Anal fistula, simple, unspecified
• K60.32 — Anal fistula, complex
• K60.321 — Anal fistula, complex, initial
• K60.322 — Anal fistula, complex, persistent
• K60.323 — Anal fistula, complex, recurrent
• K60.329 — Anal fistula, complex, unspecified
• K60.40 — Rectal fistula, unspecified
• K60.41 — Rectal fistula, simple
• K60.411 — Rectal fistula, simple, initial
• K60.412 — Rectal fistula, simple, persistent
• K60.413 — Rectal fistula, simple, recurrent
• K60.419 — Rectal fistula, simple, unspecified
• K60.42 — Rectal fistula, complex
• K60.421 — Rectal fistula, complex, initial
• K60.422 — Rectal fistula, complex, persistent
• K60.423 — Rectal fistula, complex, recurrent
• K60.429 — Rectal fistula, complex, unspecified
• K60.50 — Anorectal fistula, unspecified
• K60.51 — Anorectal fistula, simple
• K60.511 — Anorectal fistula, simple, initial
• K60.512 — Anorectal fistula, simple, persistent
• K60.513 — Anorectal fistula, simple, recurrent
• K60.519 — Anorectal fistula, simple, unspecified
• K60.52 — Anorectal fistula, complex
• K60.521 — Anorectal fistula, complex, initial
• K60.522 — Anorectal fistula, complex, persistent
• K60.523 — Anorectal fistula, complex, recurrent
• K60.529 — Anorectal fistula, complex, unspecified

L00-L99 — Diseases of the Skin and Subcutaneous Tissue (8)

• L29.81 — Cholestatic pruritus
• L29.89 — Other pruritus
• L66.10 — Lichen planopilaris, unspecified
• L66.11 — Classic lichen planopilaris
• L66.12 — Frontal fibrosing alopecia
• L66.19 — Other lichen planopilaris
• L66.81 — Central centrifugal cicatricial alopecia
• L66.89 — Other cicatricial alopecia

M00-M99 — Diseases of the Musculoskeletal System and Connective Tissue (40)

• M51.360 — Other intervertebral disc degeneration, lumbar region with discogenic back pain only
• M51.361 — Other intervertebral disc degeneration, lumbar region with lower extremity pain only
• M51.362 — Other intervertebral disc degeneration, lumbar region with discogenic back pain and lower extremity pain
• M51.369 — Other intervertebral disc degeneration, lumbar region without mention of lumbar back pain or lower extremity pain
• M51.370 — Other intervertebral disc degeneration, lumbosacral region with discogenic back pain only
• M51.371 — Other intervertebral disc degeneration, lumbosacral region with lower extremity pain only
• M51.372 — Other intervertebral disc degeneration, lumbosacral region with discogenic back pain and lower extremity pain
• M51.379 — Other intervertebral disc degeneration, lumbosacral region without mention of lumbar back pain or lower extremity pain
• M62.85 — Dysfunction of the multifidus muscles, lumbar region
• M65.90 — Unspecified synovitis and tenosynovitis, unspecified site
• M65.91 — Unspecified synovitis and tenosynovitis, shoulder
• M65.911 — Unspecified synovitis and tenosynovitis, right shoulder
• M65.912 — Unspecified synovitis and tenosynovitis, left shoulder
• M65.919 — Unspecified synovitis and tenosynovitis, unspecified shoulder
• M65.92 — Unspecified synovitis and tenosynovitis, upper arm
• M65.921 — Unspecified synovitis and tenosynovitis, right upper arm
• M65.922 — Unspecified synovitis and tenosynovitis, left upper arm
• M65.929 — Unspecified synovitis and tenosynovitis, unspecified upper arm
• M65.93 — Unspecified synovitis and tenosynovitis, forearm
• M65.931 — Unspecified synovitis and tenosynovitis, right forearm
• M65.932 — Unspecified synovitis and tenosynovitis, left forearm
• M65.939 — Unspecified synovitis and tenosynovitis, unspecified forearm
• M65.94 — Unspecified synovitis and tenosynovitis, hand
• M65.941 — Unspecified synovitis and tenosynovitis, right hand
• M65.942 — Unspecified synovitis and tenosynovitis, left hand
• M65.949 — Unspecified synovitis and tenosynovitis, unspecified hand
• M65.95 — Unspecified synovitis and tenosynovitis, thigh
• M65.951 — Unspecified synovitis and tenosynovitis, right thigh
• M65.952 — Unspecified synovitis and tenosynovitis, left thigh
• M65.959 — Unspecified synovitis and tenosynovitis, unspecified thigh
• M65.96 — Unspecified synovitis and tenosynovitis, lower leg
• M65.961 — Unspecified synovitis and tenosynovitis, right lower leg
• M65.962 — Unspecified synovitis and tenosynovitis, left lower leg
• M65.969 — Unspecified synovitis and tenosynovitis, unspecified lower leg
• M65.97 — Unspecified synovitis and tenosynovitis, ankle and foot
• M65.971 — Unspecified synovitis and tenosynovitis, right ankle and foot
• M65.972 — Unspecified synovitis and tenosynovitis, left ankle and foot
• M65.979 — Unspecified synovitis and tenosynovitis, unspecified ankle and foot
• M65.98 — Unspecified synovitis and tenosynovitis, other site
• M65.99 — Unspecified synovitis and tenosynovitis, multiple sites

Q00-QA1 — Congenital Malformations, Deformations and Chromosomal Abnormalities (4)

• Q23.81 — Bicuspid aortic valve
• Q23.82 — Congenital mitral valve cleft leaflet
• Q23.88 — Other congenital malformations of aortic and mitral valves
• Q87.86 — Kleefstra syndrome

R00-R99 — Symptoms, Signs and Abnormal Clinical and Laboratory Findings, Not Elsewhere Classified (1)

• R41.85 — Anosognosia

S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (42)

• T45.A — Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs
• T45.AX — Poisoning by, adverse effect of and underdosing of immune checkpoint inhibitors and immunostimulant drugs
• T45.AX1 — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional)
• T45.AX1A — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), initial encounter
• T45.AX1D — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), subsequent encounter
• T45.AX1S — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, accidental (unintentional), sequela
• T45.AX2 — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm
• T45.AX2A — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, initial encounter
• T45.AX2D — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, subsequent encounter
• T45.AX2S — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, intentional self-harm, sequela
• T45.AX3 — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault
• T45.AX3A — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, initial encounter
• T45.AX3D — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, subsequent encounter
• T45.AX3S — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, assault, sequela
• T45.AX4 — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined
• T45.AX4A — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, initial encounter
• T45.AX4D — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, subsequent encounter
• T45.AX4S — Poisoning by immune checkpoint inhibitors and immunostimulant drugs, undetermined, sequela
• T45.AX5 — Adverse effect of immune checkpoint inhibitors and immunostimulant drugs
• T45.AX5A — Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, initial encounter
• T45.AX5D — Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter
• T45.AX5S — Adverse effect of immune checkpoint inhibitors and immunostimulant drugs, sequela
• T45.AX6 — Underdosing of immune checkpoint inhibitors and immunostimulant drugs
• T45.AX6A — Underdosing of immune checkpoint inhibitors and immunostimulant drugs, initial encounter
• T45.AX6D — Underdosing of immune checkpoint inhibitors and immunostimulant drugs, subsequent encounter
• T45.AX6S — Underdosing of immune checkpoint inhibitors and immunostimulant drugs, sequela
• T81.320 — Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure
• T81.320A — Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, initial encounter
• T81.320D — Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, subsequent encounter
• T81.320S — Disruption or dehiscence of gastrointestinal tract anastomosis, repair, or closure, sequela
• T81.321 — Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia
• T81.321A — Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, initial encounter
• T81.321D — Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, subsequent encounter
• T81.321S — Disruption or dehiscence of closure of internal operation (surgical) wound of abdominal wall muscle or fascia, sequela
• T81.328 — Disruption or dehiscence of closure of other specified internal operation (surgical) wound
• T81.328A — Disruption or dehiscence of closure of other specified internal operation (surgical) wound, initial encounter
• T81.328D — Disruption or dehiscence of closure of other specified internal operation (surgical) wound, subsequent encounter
• T81.328S — Disruption or dehiscence of closure of other specified internal operation (surgical) wound, sequela
• T81.329 — Deep disruption or dehiscence of operation wound, unspecified
• T81.329A — Deep disruption or dehiscence of operation wound, unspecified, initial encounter
• T81.329D — Deep disruption or dehiscence of operation wound, unspecified, subsequent encounter
• T81.329S — Deep disruption or dehiscence of operation wound, unspecified, sequela

Z00-Z99 — Factors Influencing Health Status and Contact with Health Services (31)

• Z15.1 — Genetic susceptibility to epilepsy and neurodevelopmental disorders
• Z15.2 — Genetic susceptibility to obesity
• Z17.2 — Progesterone receptor status
• Z17.21 — Progesterone receptor positive status
• Z17.22 — Progesterone receptor negative status
• Z17.3 — Human epidermal growth factor 2 receptor
• Z17.31 — Human epidermal growth factor receptor 2 positive status
• Z17.32 — Human epidermal growth factor receptor 2 negative status
• Z17.4 — Combined receptor status
• Z17.41 — Hormone receptor positive
• Z17.410 — Hormone receptor positive with human epidermal growth factor receptor 2 positive status
• Z17.411 — Hormone receptor positive with human epidermal growth factor receptor 2 negative status
• Z17.42 — Hormone receptor negative
• Z17.420 — Hormone receptor negative with human epidermal growth factor receptor 2 positive status
• Z17.421 — Hormone receptor negative with human epidermal growth factor receptor 2 negative status
• Z51.A — Encounter for sepsis aftercare
• Z59.71 — Insufficient health insurance coverage
• Z59.72 — Insufficient welfare support
• Z67.A — Duffy phenotype
• Z67.A1 — Duffy null
• Z67.A2 — Duffy a positive
• Z67.A3 — Duffy b positive
• Z67.A4 — Duffy a and b positive
• Z68.55 — Body mass index [BMI] pediatric, 120% of the 95th percentile for age to less than 140% of the 95th percentile for age
• Z68.56 — Body mass index [BMI] pediatric, greater than or equal to 140% of the 95th percentile for age
• Z83.72 — Family history of familial adenomatous polyposis
• Z86.0100 — Personal history of colon polyps, unspecified
• Z86.0101 — Personal history of adenomatous and serrated colon polyps
• Z86.0102 — Personal history of hyperplastic colon polyps
• Z86.0109 — Personal history of other colon polyps
• Z92.26 — Personal history of immune checkpoint inhibitor therapy

• T81.32XA — Disruption of internal operation (surgical) wound, not elsewhere classified, initial encounter
• T81.32XD — Disruption of internal operation (surgical) wound, not elsewhere classified, subsequent encounter
• T81.32XS — Disruption of internal operation (surgical) wound, not elsewhere classified, sequela

• A77.41 — Ehrlichiosis chaffeensis [E. chaffeensis]
  Ehrlichiosis chafeensis [E. chafeensis] → Ehrlichiosis chaffeensis [E. chaffeensis]
• F98.21 — Rumination disorder of infancy and childhood
  Rumination disorder of infancy → Rumination disorder of infancy and childhood
• G93.42 — Megalencephalic leukoencephalopathy with subcortical cysts
  Megaloencephalic leukoencephalopathy with subcortical cysts → Megalencephalic leukoencephalopathy with subcortical cysts
• H44.2A3 — Degenerative myopia with choroidal neovascularization, bilateral
  Degenerative myopia with choroidal neovascularization, bilateral eye → Degenerative myopia with choroidal neovascularization, bilateral
• H44.2B3 — Degenerative myopia with macular hole, bilateral
  Degenerative myopia with macular hole, bilateral eye → Degenerative myopia with macular hole, bilateral
• H44.2C3 — Degenerative myopia with retinal detachment, bilateral
  Degenerative myopia with retinal detachment, bilateral eye → Degenerative myopia with retinal detachment, bilateral
• H44.2D3 — Degenerative myopia with foveoschisis, bilateral
  Degenerative myopia with foveoschisis, bilateral eye → Degenerative myopia with foveoschisis, bilateral
• H44.2E3 — Degenerative myopia with other maculopathy, bilateral
  Degenerative myopia with other maculopathy, bilateral eye → Degenerative myopia with other maculopathy, bilateral
• I26.93 — Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
  Single subsegmental pulmonary embolism without acute cor pulmonale → Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
• I26.94 — Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
  Multiple subsegmental pulmonary emboli without acute cor pulmonale → Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
• K58.9 — Irritable bowel syndrome, unspecified
  Irritable bowel syndrome without diarrhea → Irritable bowel syndrome, unspecified
• Q13.81 — Rieger anomaly
  Rieger's anomaly → Rieger anomaly
• Z17 — Estrogen, and other hormones and factors receptor status
  Estrogen receptor status → Estrogen, and other hormones and factors receptor status
• Z68.54 — Body mass index [BMI] pediatric, 95th percentile for age to less than 120% of the 95th percentile for age
  Body mass index [BMI] pediatric, greater than or equal to 95th percentile for age → Body mass index [BMI] pediatric, 95th percentile for age to less than 120% of the 95th percentile for age
• Z86.010 — Personal history of colon polyps
  Personal history of colonic polyps → Personal history of colon polyps

• A77.41 — Ehrlichiosis chaffeensis [E. chaffeensis]
  Ehrlichiosis chafeensis [E. chafeensis] → Ehrlichiosis chaffeensis [E. chaffeensis]
• F98.21 — Rumination disorder of infancy and childhood
  Rumination disorder of infancy → Rumination disorder of infancy and childhood
• G93.42 — Megalencephalic leukoencephalopathy with subcortical cysts
  Megaloencephalic leukoencephalopathy with subcortical cysts → Megalencephalic leukoencephalopathy with subcortical cysts
• H44.2A3 — Degenerative myopia with choroidal neovascularization, bilateral
  Degeneratv myopia with choroidal neovascularization, bi eye → Degeneratv myopia with choroidal neovascularization, bi
• H44.2B3 — Degenerative myopia with macular hole, bilateral
  Degenerative myopia with macular hole, bilateral eye → Degenerative myopia with macular hole, bilateral
• H44.2C3 — Degenerative myopia with retinal detachment, bilateral
  Degenerative myopia with retinal detachment, bilateral eye → Degenerative myopia with retinal detachment, bilateral
• H44.2D3 — Degenerative myopia with foveoschisis, bilateral
  Degenerative myopia with foveoschisis, bilateral eye → Degenerative myopia with foveoschisis, bilateral
• H44.2E3 — Degenerative myopia with other maculopathy, bilateral
  Degenerative myopia with other maculopathy, bilateral eye → Degenerative myopia with other maculopathy, bilateral
• I26.93 — Single subsegmental thrombotic pulmonary embolism without acute cor pulmonale
  Single subsegmental pulmon emblsm w/o acute cor pulmonale → Sing subsegmental throm pulm emblsm w/o acute cor pulmonale
• I26.94 — Multiple subsegmental thrombotic pulmonary emboli without acute cor pulmonale
  Mult subsegmental pulmon emboli without acute cor pulmonale → Mult subsegmental throm pulm emboli w/o acute cor pulmonale
• K58.9 — Irritable bowel syndrome, unspecified
  Irritable bowel syndrome without diarrhea → Irritable bowel syndrome, unspecified
• Q13.81 — Rieger anomaly
  Rieger's anomaly → Rieger anomaly
• Z17 — Estrogen, and other hormones and factors receptor status
  Estrogen receptor status → Estrogen, and other hormones and factors receptor status
• Z68.54 — Body mass index [BMI] pediatric, 95th percentile for age to less than 120% of the 95th percentile for age
  Body mass index pediatric, > or equal to 95% for age → Body mass index ped, 95% for age to < 120% of 95% for age
• Z86.010 — Personal history of colon polyps
  Personal history of colonic polyps → Personal history of colon polyps

• C83.39
• C86.0
• C86.1
• C86.2
• C86.3
• C86.4
• C86.5
• C86.6
• C88.0
• C88.2
• C88.3
• C88.4
• C88.8
• C88.9
• E34.0
• E66.8
• F50.01
• F50.02
• F50.2
• F50.81
• G90.8
• K60.3
• K60.4
• K60.5
• L29.8
• L66.1
• L66.8
• M51.36
• M51.37
• M65.9
• Q23.8
• Z59.7
• Z86.010 — Personal history of colon polyps